125 related articles for article (PubMed ID: 3049565)
1. Characterization and partial purification of a non-interferon macrophage activating factor produced by human leukemic T cell line.
Kutsukake H; Imai K; Harada T; Morikawa S; Tanaka A
J Biochem; 1988 Apr; 103(4):661-6. PubMed ID: 3049565
[TBL] [Abstract][Full Text] [Related]
2. Production of macrophage activating factor by human leukemic T cell lines.
Imai K; Suzuki Y; Harada T; Morikawa S; Tanaka A
Microbiol Immunol; 1985; 29(8):769-81. PubMed ID: 3906371
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
4. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
5. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
7. Human macrophage-activating factors for cytotoxicity. II. Synergism of two factors produced by a human T-cell hybridoma that induce the cytotoxicity of human monocytes.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):481-90. PubMed ID: 3116372
[TBL] [Abstract][Full Text] [Related]
8. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
[TBL] [Abstract][Full Text] [Related]
9. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
Nathan CF; Murray HW; Wiebe ME; Rubin BY
J Exp Med; 1983 Sep; 158(3):670-89. PubMed ID: 6411853
[TBL] [Abstract][Full Text] [Related]
10. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada A; Gray PW; Rinderknecht E; Schreiber RD
J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
[TBL] [Abstract][Full Text] [Related]
13. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
14. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
15. A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF).
Jones MP; Gunapala DE; Matutes E; Catovsky D; Coates AR
Cell Immunol; 1988 May; 113(2):361-75. PubMed ID: 2834073
[TBL] [Abstract][Full Text] [Related]
16. Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor.
Osada H; Furukawa-Nakanishi K; Miyamoto D; Kobayashi Y; Osawa T
Lymphokine Res; 1989; 8(4):393-405. PubMed ID: 2509820
[TBL] [Abstract][Full Text] [Related]
17. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
18. Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary's cells.
Jones CM; Prince CA; Langford MP; Hester JP
J Immunol; 1986 Jul; 137(2):571-7. PubMed ID: 3088103
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activating factor is not identical with immune interferon or a factor inducing differentiation of mouse myeloid leukemic cells.
Yamamoto Y; Tomida M; Hozumi M
Gan; 1982 Aug; 73(4):557-64. PubMed ID: 6818089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]